Berberine inhibits myofibroblast differentiation in nasal polyp-derived fibroblasts via the p38 pathway

Phytotherapy Research

Volumn 27, Issue 1, 2013, Pages 16-20

  Moon, You Mi ^a   Park, Il Ho ^b   Cho, Jung Sun ^a   Um, Ji Young ^a   Kim, Tae Hoon ^b   Lee, Heung Man ^a,b  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

alpha smooth muscle actin; berberine; collagen; mitogen activated protein kinase; myofibroblast; nasal polyp; smad; transforming growth factor

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALPHA SMOOTH MUSCLE ACTIN; BERBERINE; COLLAGEN TYPE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CLINICAL ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; MOLECULAR DYNAMICS; MYOFIBROBLAST; NOSE POLYP; P38 SIGNALING PATHWAY; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ACTINS; ADULT; BERBERINE; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN TYPE I; FEMALE; HUMANS; MALE; MYOFIBROBLASTS; NASAL POLYPS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84872075648     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4665     Document Type: Article

References (15)

1. Barbaro V, Ferrari S, Fasolo A, Ponzin D, Di Iorio E,. 2009. Reconstruction of a human hemicornea through natural scaffolds compatible with the growth of corneal epithelial stem cells and stromal keratocytes. Mol Vis 15: 2084-2093.
2. Blobe GC, Schiemann WP, Lodish HF,. 2000. Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350-1358.
3. Bokemeyer D, Sorokin A, Dunn MJ,. 1996. Multiple intracellular MAP kinase signaling cascades. Kidney Int 49: 1187-1198.
4. Hellquist HB,. 1996. Nasal polyps update. Histopathology. Allergy Asthma Proc 17: 237-242.
5. Iizuka N, Miyamoto K, Okita K, et al,. 2000. Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett 148: 19-25.
6. Ikram M., 1975. A review on the chemical and pharmacological aspects of genus Berberis. Planta Med 28: 353-358.
7. Imanshahidi M, Hosseinzadeh H,. 2008. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 22: 999-1012.
8. Kakoi H, Hiraide F,. 1987. A histological study of formation and growth of nasal polyps. Acta Otolaryngol 103: 137-144.
9. Marinova EK, Nikolova DB, Popova DN, Gallacher GB, Ivanovska ND,. 2000. Suppression of experimental autoimmune tubulointerstitial nephritis in BALB/c mice by berberine. Immunopharmacology 48: 9-16.
10. Moustakas A, Heldin CH,. 2005. Non-Smad TGF-beta signals. J Cell Sci 118: 3573-3584.
11. Nakagawa T, Yamane H, Nakai Y, Shigeta T, Takashima T, Takeda Z,. 1998. Comparative assessment of cell proliferation and accumulation of extracellular matrix in nasal polyps. Acta Otolaryngol Suppl 538: 205-208.
12. Park HH, Park IH, Cho JS, Lee YM, Lee HM,. 2010. The effect of macrolides on myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts. Am J Rhinol Allergy 24: 348-353.
13. Pawankar R., 2003. Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol 3: 1-6.
14. Sun X, Zhang X, Hu H, et al,. 2009. Berberine inhibits hepatic stellate cell proliferation and prevents experimental liver fibrosis. Biol Pharm Bull 32: 1533-1537.
15. Wang QP, Escudier E, Roudot-Thoraval F, Abd-Al Samad I, Peynegre R, Coste A,. 1997. Myofibroblast accumulation induced by transforming growth factor-beta is involved in the pathogenesis of nasal polyps. Laryngoscope 107: 926-931.